J. Taillefer

发表

Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs.

J. Taillefer, M. Jones, N. Brasseur, 2000, Journal of pharmaceutical sciences.

Early exposure to interleukin-21 limits rapidly generated anti-Epstein-Barr virus T-cell line differentiation.

J. Taillefer, D. Roy, Manon Richaud, 2015, Cytotherapy.

Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture

J. Taillefer, J. Delisle, C. Carli, 2015, Journal of Translational Medicine.

VEGF Requires the Receptor NRP-1 To Inhibit Lipopolysaccharide-Dependent Dendritic Cell Maturation

J. Taillefer, N. Labrecque, Manon Richaud, 2016, The Journal of Immunology.

Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture

J. Taillefer, J. Delisle, C. Carli, 2015, Journal of Translational Medicine.

In‐vitro and in‐vivo evaluation of pH‐responsive polymeric micelles in a photodynamic cancer therapy model

V. Lenaerts, J. Taillefer, N. Brasseur, 2001, The Journal of pharmacy and pharmacology.

Optimizing pH-responsive Polymeric Micelles for Drug Delivery in a Cancer Photodynamic Therapy Model

V. Lenaerts, J. Taillefer, J. V. van Lier, 2002, Journal of drug targeting.

Insufficient Body Weight of Adults Born With Esophageal Atresia

J. Taillefer, M. Bouin, S. Maynard, 2016, Journal of pediatric gastroenterology and nutrition.

Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs.

J. Taillefer, N. Brasseur, J. Leroux, 2000, Journal of pharmaceutical sciences.

Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.

Luis Moroder, Bernard Maigret, Céline Galés, 2003, Molecular pharmacology.